Alpha Tau Medical Ltd.
DRTS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $216,775 | $208,134 | $202,041 | $397,994 |
| - Cash | $13,724 | $12,657 | $5,836 | $23,236 |
| + Debt | $12,536 | $13,276 | $5,193 | $53,964 |
| Enterprise Value | $215,587 | $208,753 | $201,398 | $428,722 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$1,102 | -$1,074 | -$979 | -$776 |
| % Margin | – | – | – | – |
| EBITDA | -$30,298 | -$28,028 | -$32,742 | -$13,215 |
| % Margin | – | – | – | – |
| Net Income | -$31,750 | -$29,157 | -$33,762 | -$27,271 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.45 | -0.42 | -0.53 | -0.67 |
| % Growth | -7.1% | 20.8% | 20.9% | – |
| Operating Cash Flow | -$19,783 | -$17,958 | -$23,879 | -$11,812 |
| Capital Expenditures | -$2,238 | -$6,401 | -$904 | -$2,927 |
| Free Cash Flow | -$22,021 | -$24,359 | -$24,783 | -$14,739 |